Bengaluru, India

Atignal Shankara Rao Arvind

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Atignal Shankara Rao Arvind

Introduction

Atignal Shankara Rao Arvind is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of biochemistry, particularly in the development of nicotinyl riboside compounds. With a total of three patents to his name, Arvind's work focuses on enhancing cellular function and treating mitochondrial diseases.

Latest Patents

Arvind's latest patents include innovative formulations of nicotinamide riboside (NR) and nicotinic acid riboside (NAR). These compounds, along with their reduced forms (NRH and NARH), exhibit improved stability and bioavailability. The derivatives of NR and NAR can increase intracellular NAD+ levels, which is crucial for enhancing mitochondrial and cellular function. This advancement holds promise for treating various mitochondrial diseases and related conditions, either alone or in combination with other therapeutic agents.

Career Highlights

Arvind is currently associated with Mitopower LLC, where he continues to explore the therapeutic potential of his inventions. His research has garnered attention for its implications in improving health outcomes related to mitochondrial dysfunction.

Collaborations

Arvind collaborates with Gangadhara Ganapati, contributing to the advancement of their shared research interests.

Conclusion

Atignal Shankara Rao Arvind's innovative work in the field of nicotinyl riboside compounds showcases his commitment to addressing critical health issues. His contributions are paving the way for new therapeutic approaches in mitochondrial health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…